Nurul Raudzah Adib RAUDZAH ADIB Ridzuan

Dr. Nurul Raudzah Adib RAUDZAH ADIB Ridzuan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
NRNorhashima Abd Rashid
Norhashima Abd Rashid
SHSyarifah Aisyah Syed Abd Halim
Syarifah Aisyah Syed Abd Halim
STSeong Lin Teoh
Seong Lin Teoh
Siti Balkis BudinSiti Balkis Budin
Siti Balkis Budin
FHFarida Hussan
Farida Hussan
NJNahdia Afiifah Abdul Jalil
Nahdia Afiifah Abdul Jalil
Cisplatin is a potent platinum-based anticancer drug approved by the Food Drug Administration (FDA) in 1978. Despite its advantages against solid tumors, cisplatin confers toxicity to various tissues that limit its clinical uses. In cisplatin-induced hepatotoxicity, few mechanisms have been identified, which started as excess generation of reactive oxygen species that leads to oxidative stress, inflammation, DNA damage and apoptosis in the liver. Various natural products, plant extracts and oil rich in flavonoids, terpenoids, polyphenols, and phenolic acids were able to minimize oxidative stress by restoring the level of antioxidant enzymes and acting as an anti-inflammatory agent. Likewise, treatment with honey and royal jelly was demonstrated to decrease serum transaminases and scavenge free radicals in the liver after cisplatin administration. Medicinal properties of these natural products have a promising potential as a complementary therapy to counteract cisplatin-induced hepatotoxicity. This review concentrated on the protective role of several natural products, which has been proven in the laboratory findings to combat cisplatin-induced hepatotoxicity.

20 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SMSiti sarah m.sofiullah
Siti sarah m.sofiullah
DMDharmani Murugan
Dharmani Murugan
SMSUHAILA ABD MUID
SUHAILA ABD MUID
YWYuan Seng Wu
Yuan Seng Wu
SKSharifah Zamiah Syed Abdul Kadir
Sharifah Zamiah Syed Abdul Kadir
CWChoy Ker Woon
Choy Ker Woon
Cardiovascular disease (CVD) is the leading cause of death worldwide, in both developed and developing countries. According to the WHO report, the morbidity and mortality caused by CVD will continue to rise with the estimation of death going up to 22.2 million in 2030. NADPH oxidase (NOX)-derived reactive oxygen species (ROS) production induces endothelial nitric oxide synthase (eNOS) uncoupling and mitochondrial dysfunction, resulting in sustained oxidative stress and the development of cardiovascular diseases. Seven distinct members of the family have been identified of which four (namely, NOX1, 2, 4 and 5) may have cardiovascular functions. Currently, the treatment and management plan for patients with CVDs mainly depends on the drugs. However, prolonged use of prescribed drugs may cause adverse drug reactions. Therefore, it is crucial to find alternative treatment options with lesser adverse effects. Natural products have been gaining interest as complementary therapy for CVDs over the past decade due to their wide range of medicinal properties, including antioxidants. These might be due to their potent active ingredients, such as flavonoid and phenolic compounds. Numerous natural compounds have been demonstrated to have advantageous effects on cardiovascular disease via NADPH cascade. This review highlights the potential of natural products targeting NOX-derived ROS generation in treating CVDs. Emphasis is put on the activation of the oxidases, including upstream or downstream signalling events.

Verified
Journal Article
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NRNurul Raudzah Adib RAUDZAH ADIB Ridzuan
Nurul Raudzah Adib RAUDZAH ADIB Ridzuan
INIsa Naina-Mohamed
Isa Naina-Mohamed
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
The genus Acmella has received growing attention for its pharmacological properties, including its potential applications in musculoskeletal disorders (MSDs). Plants in this genus, such as Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella oleracea contain various bioactive compounds which have demonstrated anti-inflammatory, analgesic, and anti-arthritic properties. This systematic review evaluates the clinical and preclinical evidence supporting the use of plants from Acmella genus for the treatment of MSD, such as arthritis, osteoporosis, muscle injuries, joint inflammation, and other related pathologies. The methodology used in this study involved a systematic literature review, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, along with synthesis analysis and quality appraisal. The articles were retrieved from Scopus, Google Scholar, and PubMed databases. Eleven articles were further analyzed to determine the therapeutic potential of Acmella genus plants for musculoskeletal disorders. The plants included were Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella olerecia. The musculoskeletal disorders investigated were osteoporosis, osteoarthritis, and myopathies. The extracts from these plants were shown to decrease inflammation, enhance joint health, relieve pain, and stimulate osteogenic activity. These effects may be attributed to several active compounds found in these plants. The available evidence suggests that Spilanthes acmella and Blainvillea acmella have the potential to treat osteoporosis. Acmella oleracea and Acmella uliginosa have the potential to be used for the treatment of osteoarthritis, while Spilanthes acmella is used to treat myopathies. Further research is needed to establish the efficacy, optimal dosing, and safety of these plants.

4 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMohd Maaruf Abdul Malik
Mohd Maaruf Abdul Malik
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NRNurul Raudzah Adib RAUDZAH ADIB Ridzuan
Nurul Raudzah Adib RAUDZAH ADIB Ridzuan
INIsa Naina-Mohamed
Isa Naina-Mohamed
ERElvy Suhana Mohd Ramli
Elvy Suhana Mohd Ramli
RRRohanizah Abdul Rahim
Rohanizah Abdul Rahim
Background: The genus Acmella has received growing attention for its pharmacological properties, including its potential applications in musculoskeletal disorders (MSD). Plants in this genus such as Spilanthes acmella, Blainvillea acmella, Acmella uliginosa and Acmella oleracea contain various bioactive compounds which have demonstrated anti-inflammatory, analgesic, and anti-arthritic properties. This systematic review evaluates the clinical and preclinical evidence supporting the use of plants from Acmella genus for treatment of MSD such as arthritis, osteoporosis, muscle injuries, joint inflammation, and other related pathologies. Methods: The methodology used in this study involved a systematic literature review, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, along with synthesis analysis and quality appraisal. The articles were retrieved from Scopus, Google Scholar and PubMed databases. Results: Eleven articles were further analysed to determine the therapeutic potential of Acmella genus plants for musculosketelal disorders. The plants included were Spilanthes acmella, Blainvillea acmella, Acmella uliginosa, and Acmella olerecia. The musculoskeletal disorders investigated were osteoporosis, osteoarthritis and myopathies. The extracts from these plants were shown to decrease inflammation, enhance joint health, relieve pain, and stimulate osteogenic activity. These effects may be contributed with several active compounds found in these plants. Conclusions: The available evidence suggests that Spilanthes acmella and Blainvillea acmella have potential to treat osteoporosis. Acmella oleracea and Acmella uliginosa have potential to be used for treatment of osteoarthritis while Spilanthes acmella in treating myopathies. Further research is needed to establish efficacy, optimal dosing, and safety of these plants.